Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol for prevention of rebound pain after fascia iliaca block in knee arthroplasty
ChiCTR2600129126Phase 4Not yet recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain and Rebound pain comparing Esmolol infusion arm with Normal saline placebo arm (2 arms). Primary endpoint: Incidence of rebound pain after peripheral nerve block. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
esmolol
03
Conditions
postoperative painRebound pain
Beyond the preview
Go deeper on ChiCTR2600129126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129126.